<DOC>
	<DOC>NCT00824226</DOC>
	<brief_summary>Study hypothesis: supplementary magnesium may influence the blood calcium level in treated hypoparathyroid patients. Patients will be treated with supplementary magnesium (350 mg/day) for 3 weeks. Calcium and other relevant blood parameters will be measured before the treatment, at the end of treatment and 2 weeks after stopping treatment.</brief_summary>
	<brief_title>Magnesium Treatment in Hypoparathyroidism</brief_title>
	<detailed_description />
	<mesh_term>Hypoparathyroidism</mesh_term>
	<criteria>primary or secondary hypoparathyroidism treatment with calcium plus vitamin D analogue ionized calcium 1,01,29 mmol/L magnesium level 0,71,05 mmol/L TSH 0.1 10 imU/L any other disease known to influence plasma Ca level pregnancy creatinine &gt; 150 microM/L patient has used supplementary magnesium within 2 previous months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>primary hypoparathyroidism</keyword>
	<keyword>secondary hypoparathyroidism</keyword>
	<keyword>magnesium</keyword>
</DOC>